Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3371 of 6351
-
Can a sleep machine protect your heart after a stroke?
Disease control CompletedStroke affects 16.9 million individuals each year and is the second leading cause of death worldwide. Despite advances in pharmacologic therapy, morbidity , mortality and rates of hospitalization for stroke remain high. These data emphasize the importance of identifying all treat…
Sponsor: Far Eastern Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Brain scan study seeks to uncover hidden clues in Alzheimer's
Knowledge-focused Recruiting nowThe primary objective of this study is to measure the concentration and the regional brain distribution of pathologic tau deposition using the PET tracer AV-1451 in participants in the UAB-ADC cohort. The amount and distribution of AV-1451 in the brain will be correlated to demog…
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Sound waves could reveal hidden fluid in swollen limbs
Diagnosis By invitation onlyResearchers are trying to validate the use of ultrasound sub-hertz analysis of viscoelastisty (SAVE) method to monitor tissue-fluid dynamics and stage disease severity in patients diagnosed with lymphedema.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
New pill shows promise for tough blood cancers in early trial
Disease control CompletedA Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Orally Administered LP-108 as Monotherapy and in Combination with Azacitidine in Subjects with Relapsed or Refractory Myelodysplastic Syndromes (…
Phase 1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can your blood pressure cuff spot a hidden heart problem?
Diagnosis OngoingThe proposed clinical study aims to validate the diagnostic performance, compared to a reference ECG, of the electrocardiographic function of the BPM Core developed by Withings for the automatic identification of atrial fibrillation (AF).
Sponsor: Withings • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Eye fluid clues may predict who benefits from vision-saving injections
Knowledge-focused Recruiting nowThe aim of the study is to find biomarkers in the blood and aqueous humor of patients with type 1 choroidal neovascularization and correlate them with the response to anti-VEGF treatment.
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Robotic arm training may improve movement after stroke
Symptom relief Recruiting nowThis is a single-blind randomized comparative efficacy study involving 54-72 participants with chronic stroke. Participants will be randomized into proximal priority robotic group or distal priority robotic group and receive 18 intervention sessions (90 min/d, 3 d/wk for 6 weeks)…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Chat groups lift depression in mexican women
Symptom relief CompletedThis study will use a multi-level, community-engaged approach to implement "TERTULIAS" ("conversational gatherings" in Spanish). The intervention uses an innovative, culturally and contextually situated peer support group design that was developed by the investigators to improve …
Sponsor: University of New Mexico • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Gut bacteria boost: probiotics may improve diabetes control
Disease control CompletedAdult-onset diabetes is a disease characterized by high blood glucose levels and is one of the leading causes of cardiovascular disease, blindness, end-stage renal failure, and hospitalization. Recent studies support the idea that bacteria found in the gut may play an important r…
Sponsor: Ege University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New research platform aims to unlock secrets of brain metastases
Knowledge-focused Recruiting nowDespite some encouraging data, systemic treatment of CNS metastases from solid tumors remains experimental. Better knowledge on the evolving epidemiology and biology of BM are key elements for the development of new treatment strategies and identification of promising therapeuti…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New recovery plan may get kids home faster after bowel surgery
Symptom relief CompletedThe institution of perioperative Enhanced Recovery Protocols (ERPs) has been found to decrease hospital length of stay, in-hospital costs, and complications among adult surgical populations but data in pediatric populations are lacking. The Assessing Effectiveness and Implementat…
Phase 3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can sinus surgery help cystic fibrosis lungs? new study investigates
Knowledge-focused Recruiting nowThis study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control gr…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can pressurized oxygen boost stem cell transplants?
Disease control Recruiting nowThe purpose of this study is to determine if hyperbaric oxygen therapy is safe in the setting of stem cell transplantation. This study will also determine if hyperbaric oxygen therapy improves engraftment, graft versus host disease, neutrophil count, and incidence and severity of…
Early phase 1 • Sponsor: Omar Aljitawi • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One-Day workshop aims to ease Veterans' distress and reintegration
Symptom relief CompletedMild traumatic brain injury (mTBI) is the signature wound of Veterans returning from the operations in Iraq and Afghanistan (i.e., OIF/OEF/OND), with up to 20 percent experiencing persistent post-concussive symptoms. Among Veterans with mTBI, the majority also experience stress-b…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Could a Two-Drug sequence shrink tumors with fewer side effects?
Disease control OngoingThis phase I trial studies the side effects and best dose of adavosertib when given together with olaparib in treating patients with solid tumors that have spread to other places in the body (advanced) with selected mutations. Adavosertib may stop the growth of tumor cells by blo…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
UV water treatment tested to keep kids healthy
Prevention CompletedApproximately 40 million people in the US are served by private wells, many of which are untreated. The investigators estimate that 1.29 million cases of gastrointestinal illness (GI) per year are attributed to consuming water from untreated private wells in the US. These cases o…
Sponsor: Temple University • Aim: Prevention
Last updated Jun 26, 2026 14:41 UTC
-
Experimental drug shows promise in slowing duchenne muscle loss
Disease control OngoingThis is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed DS5141-A-J101.
Phase 2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC
-
New drug combo takes on Hard-to-Treat bone marrow cancer
Disease control Recruiting nowThis study will determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT), and recommended Phase 2 dose (RP2D) of SX-682 in the treatment of patients with Myelodysplastic Syndromes (MDS).
Phase 1 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New stent device aims to fix Hard-to-Treat aortic aneurysms
Disease control OngoingProspective, multi-center, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Complex Abdominal Aortic Aneurysms.
Sponsor: Endologix • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Coffee-Inspired cream may protect breast cancer patients from radiation damage
Symptom relief OngoingThe purpose of the study is to evaluate whether a caffeine-based cream can reduce the rates of reconstructive complications in patients with tissue expander based reconstruction requiring post-mastectomy radiation therapy when compared to a placebo cream.
Phase 2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC